Low-Dose Chemotherapy to Treat Burkitt Lymphoma

High dose chemotherapy has been the conventional approach to treating Burkitt Lymphoma (“BL”), one of the more aggressive forms of this disease.  However, long-term survival rates following this treatment approach have hovered only around 60% (and, of course, such treatment is highly toxic in itself, with onerous side effects).  A recent study sponsored by the National Institute […]

Featured Study- Depression as a Predictor of Disease Progression and Mortality

Because I am a big believer in the power of the mind and the importance of one’s mood in the fight against cancer, I am starting off this feature with a research study undertaken by Jillian R. Satin, MA, and her colleagues, entitled Depression as a Predictor of Disease Progression and Mortality in Cancer Patients: […]